Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

INFOGRAPHIC: IPOs surge in first half of 2014; 41 companies raise $2.6bn

This article was originally published in Scrip

Executive Summary

Could the number of biotechnology companies that go public in the US double in 2014 versus last year? Well, with 41 drug developers who completed initial public offerings as of 30 June, the industry already exceeded the 37 companies that completed IPOs in 2013.

Advertisement

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC025867

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel